SOPHiA GENETICS SA (SOPH) stock forecast and price target
Price $8.21 · data as of November 13, 2026
12-month price target
Average target$9.75
Upside / downside+18.8%
Analysts4
ConsensusStrong buy
Low $7.00Average $9.75High $14.00
Gold marker: average target · white marker: today’s price ($8.21)
Analyst ratings
Strong buy 0Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.88 | −10.9% | $96M |
| Next fiscal year ends December 31, 2027 | $-0.55 | +37.5% | $119M |
| Next quarter ends December 31, 2026 | $-0.16 | +6.3% | $26M |
| Quarter after ends March 31, 2027 | $-0.18 | +5.8% | $26M |
Consensus of the analysts covering SOPHiA GENETICS SA, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.
Frequently asked questions
What is the SOPHiA GENETICS SA stock price target?
The average 12-month target from 4 analysts is $9.75, 18.8% above the current price of $8.21 Targets range from $7.00 to $14.00.
Is SOPHiA GENETICS SA a buy according to analysts?
The consensus rating is “Strong buy” (5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is SOPHiA GENETICS SA expected to earn?
Analysts expect EPS of $-0.88 for the fiscal year ending December 31, 2026 and $-0.55 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.